OMODEI, Umberto
 Distribuzione geografica
Continente #
NA - Nord America 3.375
EU - Europa 1.200
AS - Asia 1.122
SA - Sud America 14
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 2
Totale 5.718
Nazione #
US - Stati Uniti d'America 3.372
UA - Ucraina 536
CN - Cina 418
SG - Singapore 275
HK - Hong Kong 238
DE - Germania 211
IN - India 112
FI - Finlandia 111
IT - Italia 85
IE - Irlanda 73
TR - Turchia 72
RU - Federazione Russa 60
GB - Regno Unito 57
FR - Francia 26
EE - Estonia 24
BR - Brasile 14
SE - Svezia 6
BE - Belgio 5
EU - Europa 5
NL - Olanda 3
AU - Australia 2
CA - Canada 2
IQ - Iraq 2
KR - Corea 2
AT - Austria 1
AZ - Azerbaigian 1
BD - Bangladesh 1
BY - Bielorussia 1
JO - Giordania 1
MX - Messico 1
RO - Romania 1
Totale 5.718
Città #
Fairfield 473
Woodbridge 464
Jacksonville 362
Houston 347
Ann Arbor 286
Ashburn 263
Hong Kong 238
Cambridge 214
Seattle 203
Singapore 195
Wilmington 191
Princeton 146
Nanjing 111
Dublin 73
Chandler 71
Istanbul 61
Beijing 56
Dearborn 53
Helsinki 39
Nanchang 31
Milan 25
San Diego 25
Tallinn 24
Changsha 22
Kunming 21
Jiaxing 20
Jinan 20
Hebei 19
Tianjin 19
Brescia 17
Moscow 17
Shenyang 16
Washington 15
Los Angeles 12
Hangzhou 11
Boardman 10
Kocaeli 10
London 10
Shanghai 10
Ningbo 9
Verona 9
Hefei 8
Indiana 7
New York 7
Norwalk 7
San Francisco 7
Guangzhou 6
Lanzhou 6
Brussels 5
Des Moines 4
Orange 4
Taiyuan 4
Zhengzhou 4
Fuzhou 3
Haikou 3
Nürnberg 3
Ronchi Dei Legionari 3
Berlin 2
Kolkata 2
Modena 2
Paceco 2
Rome 2
San Giacomo delle Segnate 2
Santa Clara 2
Taizhou 2
Taranto 2
Walnut 2
Yellow Springs 2
Amman 1
Angra dos Reis 1
Augusta 1
Baku 1
Bardolino 1
Cangonhal 1
Chaoyang 1
Chengdu 1
Council Bluffs 1
Dhaka 1
Falkenstein 1
Frankfurt am Main 1
Guarulhos 1
Horia 1
Hounslow 1
Huntersville 1
Iguape 1
Kilburn 1
Kirkuk 1
Markham 1
Melbourne 1
Mexico City 1
Minsk 1
New Bedfont 1
New Delhi 1
Nuremberg 1
Padenghe sul Garda 1
Paris 1
Perm 1
Redmond 1
Saint Petersburg 1
Secaucus 1
Totale 4.353
Nome #
Effect of transdermal estradiol and oral conjugated estrogen on C-reactive protein in retinoid-placebo trial in healthy women 147
Randomized dose-ranging trial of tamoxifen at low doses in hormone replacement therapy users. 123
Can salin infusion sonohysterography (SIS) replace diagnostic hysteroscopy in the uterine cavity evaluation of infertile women? 119
FSH receptor polymorphisms in a population of infertile women and controls 119
Identification of osteoporosis risk in postmenopausal women by the combined use of ultrasounds and clinical factors 117
Effect of soy-derived isoflavones on hot flushes, endometrial thickness, and the pulsatility index of the uterine and cerebral arteries 116
A phase-III prevention trial of low-dose tamoxifen in postmenopausal hormone replacement therapy users: The HOT study 114
Clinical Impact of a New Italian Law Regulation on Assisted Reproduction Technologies 112
General and medical factors associated with hormone replacement therapy among women attending menopause clinics in Italy 112
Effect of acupuncture on rates of pregnancy among women undergoing in vitro fertilization 107
Risk identification of osteoporosis in postmenopausal women by a simple algorithm based on ultrasound densitometry and body mass index 107
Risk factors for clinically diagnosed uterine fibroids in women around menopause. 107
Factors associated with total cholesterol levels in women around menopause attending menopause clinics in Italy 106
Determinants of body mass index in women around menopause attending menopause clinics in Italy. 104
Chromosome Abnormalities and Yq microdeletions in Infertile italian couples referred for assisted reproductive tecnique 102
How often are endometrial polyps malignant in asymptomatic postmenopausal women? A multicenter study. 100
Effect of soy-derived isoflavones on hot flashes, endometrial thickness, and the pulsatility index of the uterine and cerebral arteries 100
A two-by-two factorial trial comparing oral with transdermal estrogen therapy and fenretinide with placebo on breast cancer biomarkers. 99
Risk of low bone density in women attending menopause clinics in Italy 97
Risk factors for type 2 diabetes in women attending menopause clinics in Italy: a cross-sectional study. 96
Risk factors for high blood pressure in women attending menopause clinics in Italy. 96
A New HRT Regimen Using Estradiol Valerate and Cyproterone Acetate: Clinical Data 95
Determinants of age at menopause in women attending menopause clinics in Italy. 94
Trends of determinants of hormone therapy use in Italian women attending menopause clinics, 1997-2003. 92
Serum progesterone level on the day of oocyte retrieval correlates with the ovarian response but not predict pregnancy rate 92
The Effect of HRT on Endometrial Thickness (ET) and Uterine Arterial Blood Flow Assessed by Transvaginal Ultrasound (TVU). 92
Endometrial thickness and histological abnormalities in women on hormonal replacement therapy: a transvaginal ultrasound/hysteroscopic study 91
Osteoporosis Risk Profile for Peri-and Postmenopausal Women Attending Menopause Clinics in Italy 91
Ovulation induction with intravenous gonadotropin-releasing hormone 91
Endometrial Changes and Doppler Flow Evaluation in Postmenopausal Breast Cancer Patients on Tamoxifen (TAM): A Transvaginal Ultrasound (TVU)/Hysterescopy Study 90
Endometrial evaluation with transvaginal ultrasound during hormone therapy: a prospective multicenter study. 88
Risk of low bone density in women attending menopause clinics in Italy. 88
Sequential Conjugated Estrogens Plus Medrogestone HRT Regimen Versus Tibolone: A Comparative Randomized Study 88
Factors associated with climacteric symptoms in women around menopause attending menopause clinics in Italy. 88
Frequency of Cardiovascular Risks Factor in Women Attending Menopause Clinics: Findings from the ICARUS Data Base 87
A New HRT Regimen Using Estradiol Valerate and Cyproterone Acetate: Impact on Lipid Metabolism 87
Premature ovarian failure: frequency and risk factors among women attending a network of menopause clinics in Italy. 81
Risk factors for genital prolapse in non-hysterectomized women around menopause. Results from a large cross-sectional study in menopausal clinics in Italy 75
CUMCS: FINDINGS FROM THE ICARUS DATA BASE 75
Treatment of hypothalamic infertility with pulsatile GN-RH administration. 71
Profiles and endocrine correlations in endometrial carcinoma. 70
A new method for free testosterone assay: clinical evaluation. 70
A new method for free testosterone assay: clinical evaluation. 68
Anti-Mullerian hormone (AMH): Prognostic value in assisted reproductive technology (ART) 68
Pituitary microprolactinoma, bromocriptine, and pregnancy: follow-up of 74 cases 65
Endometrial Evaluation in Postmenopausal Bleeding: Transvaginal Sonografy Versus Hysteroscopy 65
Doppler flow evaluation of endometrial conditions in postmenopausal breast cancer patients treated with tamoxifen 62
Continuous combined HRT in post-menopause: two regimen comparative study 60
Rischio oncologico 60
The effect of transdermal estradiol or oral conjugated oestrogen and fenretinide versus placebo on haemostasis and cardiovascular risk biomarkers in a randomized breast cancer chemoprevention trial 57
Treatment of hypothalamic infertility with pulsatile GN-RH administration. 56
Doppler flow evaluation of endometrial conditions in postmenopausal breast cancer patients treated with tamoxifen 56
Profiles and endocrine correlations in endometrial carcinoma. 55
The effect of HRT on uterine arterial blood flow in postmenopausal women assessed by transvaginal color doppler sonography (TVDS) 55
Polycystic ovary syndrome: long-term evolution. 54
Ovarian hyperstimulation syndrome (OHS): a case of severe OHS. 54
Polycystic ovary syndrome: long-term evolution. 54
Outlook on Continuous Estrogen-Progestin Therapy. 53
Endometrial ultrasound transvaginal (TVU) assessment in postmenopausal women on hormone replacement therapy (HRT) 53
Treatment of hypothalamic infertility with pulsatile GN-RH administration. 53
The impact of HRT on endometrial thickness—do cut‐off values exist? 52
Effects of Recombinant Follicle-Stimulating Hormone on Bone Turnover Markers in Infertile Women Undergoing in Vitro Fertilization Procedure 51
Premarin 0.625 vs Estraderm TTS 50 Have These Two" Standard Doses" the Same Biological Effects? 50
Endometrial changes in postmenopausal breast cancer patients receiving tamoxifen: a transvaginal ultrasound study 49
Mammella: è possibile la chemioprevenzione? 49
EFFECTS OF SOY-DERIVED ISOFLAVONES ON HOT FLUSHES AND VASCULAR REACTIVITY 48
Endometrial ultrasound transvaginal (TVU) assessment in postmenopausal women on hormone replacement therapy (HRT) 48
EVALUATION OF BLEEDING AND CONTROL OF CLIMACTERIC SYMPTOMS OBSERVED WITH TWO TRANSDERMAL PREPARATIONS CONTAINING ESTRADIOL AND NORETHISTERONE ACETATE 47
Endometrial changes in postmenopausal breast cancer patients receiving tamoxifen: a transvaginal ultrasound study 45
Fibrocystic Disease of the Breast Associated with Pituitary‐Ovarian Dysfunction: Results of Treatment with Bromocriptine 44
The effect of HRT on uterine arterial blood flow in postmenopausal women assessed by transvaginal color doppler sonography (TVDS) 44
Identificazione del rischio di osteoporosi in donne in postmenopausa mediante l’uso combinato di ultrasuoni e fattori clinici. 43
La patologia endometriale e la sorveglianza della paziente in postmenopausa 43
Totale 5.757
Categoria #
all - tutte 27.762
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.762


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020449 0 0 0 0 0 0 0 0 95 193 60 101
2020/2021911 5 136 9 103 23 142 25 144 105 102 98 19
2021/2022460 14 119 3 28 1 40 27 39 35 52 8 94
2022/2023296 75 1 6 27 20 100 0 19 26 3 6 13
2023/2024378 10 2 35 43 22 46 18 12 103 20 2 65
2024/2025621 4 1 7 187 134 81 142 19 46 0 0 0
Totale 5.757